SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019)
SELLAS Life Sciences' (SLS) quarterly Deferred Taxes came in at -$95000.0 in Q4 2019, up 93.04% year-on-year from -$49212.5 in Q4 2018, and up 93.04% on a QoQ basis from -$1.4 million in Q4 2018.
SELLAS Life Sciences (SLS) Deferred Taxes (2013 - 2019) Analysis & Trends
SELLAS Life Sciences (SLS) has 4 years of Deferred Taxes data on file, last reported at -$95000.0 in Q4 2019.
- On a quarterly basis, Deferred Taxes rose 93.04% year-over-year to -$95000.0 in Q4 2019; TTM through Dec 2019 was -$1.5 million, a 7.04% decrease from a year earlier, with the FY2021 full-year figure at -$239000.0, down 939.13% from the prior year.
- Deferred Taxes for Q4 2019 stood at -$95000.0, up from -$1.4 million in the prior quarter.
- Over the last five years, Deferred Taxes for SLS reached as high as $1000.0 in Q3 2017 and fell as low as -$1.4 million in Q4 2018.
- Historically, Deferred Taxes has averaged -$486333.3 across 3 years, with a median of -$95000.0 in 2019.
- On a YoY basis, Deferred Taxes climbed as much as 93.04% in 2019 and fell as far as 93.04% in 2019.
- Year by year, Deferred Taxes stood at $1000.0 in 2017, then sank by 136600.0% to -$1.4 million in 2018, then jumped by 93.04% to -$95000.0 in 2019.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$95000.0 in Q4 2019, -$1.4 million in Q4 2018, and $1000.0 in Q3 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -95,000.00 |
| Dec 31, 2018 | -1.37 Mn |
| Sep 30, 2017 | 1,000.00 |
| Dec 31, 2013 | 1.12 Mn |
| Sep 30, 2013 | 1.16 Mn |
| Jun 30, 2013 | 1.54 Mn |
| Mar 31, 2013 | -2.76 Mn |